Blue Jet Healthcare
BLUEJET · Pharma > Pharmaceuticals & Drugs Listing date: Nov. 1, 2023

Stock Price vs Company Growth
1d
4.2%
1w
0.4%
1m
11.2%
3m
11.6%
6m
39.3%
1y
37.2%
all
31.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 527 4.2%
459
578
Company Overview

Sales
722 Cr
Growth: -7.7%
Profit after Tax
168 Cr
Growth: 6.7%
Mid Cap
9,140 Cr
P/E: 54.4x
Industry P/E: 35.6x
Fundamentals

Sales (Cr) ₹ 722
Growth -7.7%
EBITDA 30.7%
P/S 12.7x
Dividend 0.0%
P/E 54.4x
Book Value ₹ 54.3
PEG Ratio -7.1x
ROE 19.3%
P/B 9.7x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is a global, science-led, pharmaceutical company evolved as Strategic Partner for Collaboration, Development & Manufacturing of advance Pharmaceutical Intermediates and API.